L. Peyrin-Biroulet, K. Khosrotehrani, F. Carrat, A. M. Bouvier, J. B. Chevaux, T. Smon, F. Carbonnel, J. F. Colombel, J. L. Dupas, P. Godeberege, J. P. Hugot, M. Lemann, S. Nahon, J. M. Sabate, G. Tucat, L. Beaugerie, Cesame Study Grpup, “Increased risk for nonmelanoma skin cancers in patients who receive Thiopurines for inflammatory bowel disease,” Gastroenterology, Vol. 141, No. 5, 2011, pp. 1621-1628.

has been cited by the following article:

• TITLE: Re-Evaluation of Acquired Epidermodysplasia Verruciformis in Kidney Transplant Recipients

  AUTHORS: Khalifa E. Sharquie, Adil A. Noaimi, Ali A. Al-Jobori

  KEYWORDS: Acquired Epidermodysplasia Verruciformisin; Kidney Transplant; Tumors

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.2 No.3, September 17, 2012

  ABSTRACT: Background: Epidermodysplasia verruciformis (EV) is a skin disease associated with numerous early onset viral warts on the sun exposed parts of the body that usually progress into different skin malignancies. Kidney transplant patients are also commonly associated with viral warts that might change into skin cancers. Objective: To re-evaluate all features of the acquired epidermodysplasia verruciformis in kidney transplant patients in comparison with healthy individuals. Patients and Methods: This case controlled study that included 100 patients with kidney transplantation(87 males, 13 females) their ages ranged from 14-70(46.65 ± 4.74) years and was done in kidney Transplantation Centers in Baghdad and Al-Karma Teaching Hospitals from June 2009-August 2010. Patients included were receiving multiple immunosuppressive drugs like azathioprine, prednisolone, cyclosporine, mycophenolate mofetil ranged from 6 months-25 years. One hundred healthy individuals (70 males, 30 females), there ages ranged from 14-73 (41.63 ± 9.55) years, had been examined as a control for the presence of viral warts and tumors. These control cases had been taken randomly from general population in multiple regions in Baghdad Results: Forty (40%) patients out of one hundred kidney transplant patients had viral warts and were seen in 9(9%) of control group and there was statistically significant difference between patients and control cases (P value